Author

Vivek Tanavde

Agency for Science, Technology and ResearchORCID 0000-0001-7404-5568Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vivek Tanavde1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Aditi PateliD· 1 shared Binita Patel· 1 shared Dhiraj Devidas BhatiaiD· 1 shared Dushyant S MandlikiD· 1 shared Jonathan S.L. TaniD· 1 shared Kaid JohariD· 1 shared Kaustubh D. Patel· 1 shared Prabha SampathiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aditi PatelORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 9, 2026

Inhibition of miR-1307 Reverses Resistance to Cisplatin in Drug-Resistant Oral Squamous Cell Carcinoma

Aditi Patel, Vaishnavi Patel, Shreya Lotia…·Shanaya Patel

This study identifies miR-1307-5p in salivary extracellular vesicles as a biomarker of chemoresistance in oral squamous cell carcinoma and shows its inhibition restores cisplatin sensitivity.

DOI 10.64898/2026.04.06.709730

humanbulk RNA-seq

𝕏 PostBluesky